CHRISTIANNE BRETAS VIEIRA SCARAMELLO

Dr. CHRISTIANNE BRETAS VIEIRA SCARAMELLO

Phisiology & Pharmacology, Fluminense Federal University, Niterói, Rio de Janeiro, Brazil

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Toxicology
Verified
Journal Article
Closed access
AMAna Beatriz Araújo Mendes
Ana Beatriz Araújo Mendes
NMNadia Alice Vieira Motta
Nadia Alice Vieira Motta
GLGabriel Ferreira Lima
Gabriel Ferreira Lima
LALis Jappour Autran
Lis Jappour Autran
SBStephani Correia Brazão
Stephani Correia Brazão
FBFernanda Carla Ferreira Brito
Fernanda Carla Ferreira Brito

10 June 2023 in Life
Verified
Journal Article
Open access
PDF file
IMIvis Levy Fernandes Martins
Ivis Levy Fernandes Martins
FAFlávia Valéria dos Santos Almeida
Flávia Valéria dos Santos Almeida
KSKaryne Pollo de Souza
Karyne Pollo de Souza
FBFernanda Carla Ferreira de Brito
Fernanda Carla Ferreira de Brito
Gabriel RodriguesGabriel Rodrigues
Gabriel Rodrigues
CSCHRISTIANNE BRETAS VIEIRA SCARAMELLO
CHRISTIANNE BRETAS VIEIRA SCARAMELLO
Atrial fibrillation (AF) is the most common type of sustained arrhythmia. The numerous gaps concerning the knowledge of its mechanism make improving clinical management difficult. As omics technologies allow more comprehensive insight into biology and disease at a molecular level, bioinformatics encompasses valuable tools for studying systems biology, as well as combining and modeling multi-omics data and networks. Network medicine is a subarea of network biology where disease traits are considered perturbations within the interactome. With this approach, potential disease drivers can be revealed, and the effect of drugs, novel or repurposed, used alone or in combination, may be studied. Thus, this work aims to review AF pathology from a network medicine perspective, helping researchers to comprehend the disease more deeply. Essential concepts involved in network medicine are highlighted, and specific research applying network medicine to study AF is discussed. Additionally, data integration through literature mining and bioinformatics tools, with network building, is exemplified. Together, all of the data show the substantial role of structural remodeling, the immune system, and inflammation in this disease etiology. Despite this, there are still gaps to be filled about AF.

6 July 2020 in Journal of Nutritional Science
Verified
Journal Article
Open access
PDF file
GAGracielle Amaral de Araújo
Gracielle Amaral de Araújo
RFRaysa da Silva Farias
Raysa da Silva Farias
SPSamuel de Sousa Pedro
Samuel de Sousa Pedro
NRNazareth N. Rocha
Nazareth N. Rocha
FBFernanda C. F. Brito
Fernanda C. F. Brito
CSCHRISTIANNE BRETAS VIEIRA SCARAMELLO
CHRISTIANNE BRETAS VIEIRA SCARAMELLO
Litter size reduction can induce early overnourishment, being an attractive experimental model to study short- and long-term consequences of childhood obesity. Epidemiological data indicate sex differences regarding cardiometabolic disorders and hypertrophic cardiomyopathy. The present study aimed to describe biometric, nutritional and cardiovascular changes related to neonatal overweight promoted by litter size reduction in young and adult Wistar rats of both sexes. Litter adjustment to eight or four pups/mother (1:1 male-to-female ratio) gave, respectively, control and overweight groups. Body mass, food intake, haemodynamic and echocardiographic parameters and cardiorespiratory capacity were evaluated at postnatal days 30 and 150. Diminished litters were correlated with higher body mass and weight gain (12 %) during lactation, validating the experimental model of neonatal overweight. Soon after weaning male (16 %) and female (25 %) offspring of these litters presented a lower food intake than their respective control, without differences in body mass. Adult males from reduced litters presented higher abdominal circumference (7 %), systolic blood pressure (10 %), interventricular septum thickness (15 %) and relative wall thickness (15 %) compared with their respective control. Rats' performance on the maximal effort ergometer test was not affected by neonatal overweight. Data suggest the occurrence of catch-down growth and hypophagia in male and female rats submitted to neonatal overweight. However, only male rats presented haemodynamic and cardiac structural changes. These findings are crucial to personalised/gender medicine.

15 May 2015 in Anais da Academia Brasileira de Ciências
Verified
Journal Article
Open access
PDF file
FSFelipe C. Souza
Felipe C. Souza
EMEmiliana B. Marques
Emiliana B. Marques
RSRogério B.M. Scaramello
Rogério B.M. Scaramello
CSCHRISTIANNE BRETAS VIEIRA SCARAMELLO
CHRISTIANNE BRETAS VIEIRA SCARAMELLO
Digoxin is used for heart failure associated to systolic dysfunction and high ventricular rate. It has a narrow therapeutic range and intoxication may occur due to drug interactions or comorbidities. The aim of this work was to study digoxin use in a public health unit delineating the profile of patients susceptible to digitalis intoxication. Medical records belonging to patients admitted to the cardiomyopathy ward of the health unit (2009-2010) and in use of digoxin were analyzed. Among 647 patients admitted, 185 individuals using digoxin and possessed records available. The registration of plasma digoxin concentration was found in 80 records and it was out of the therapeutic range in 42 patients (52.5%). This group of individuals was constituted mainly by males patients (79%), functional class III of heart failure (65%), exhibiting renal failure (33%). The evaluated sample reflects the epidemiology of heart failure in Brazil and, although pharmacotherapy had been according to Brazilian Guidelines, apparently the monitoring was not performed as recommended. This work highlighs the necessity of plasma digoxin constant monitoring during pharmacotherapy and the development of protocols that enable a safer use, especially in male patients, functional class III and with renal dysfunction.

6 January 2019 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
NMNadia A. V. Motta
Nadia A. V. Motta
MFMilla M. Fumian
Milla M. Fumian
RMRenata F. Medeiros
Renata F. Medeiros
GLGabriel F. Lima
Gabriel F. Lima
CSCHRISTIANNE BRETAS VIEIRA SCARAMELLO
CHRISTIANNE BRETAS VIEIRA SCARAMELLO
FBFernanda C. F. Brito
Fernanda C. F. Brito
Background. Increased platelet response is seen in individuals with metabolic syndrome. Previous reports have shown that arginine supplementation and aerobic exercise training enhance vascular nitric oxide (NO) activity and inhibit platelet hyperaggregability; however, the effects of their association remain unknown.Aim. To investigate whether arginine supplementation and aerobic exercise association may exert beneficial effects, reducing platelet hyperaggregability in rats under high risk to develop metabolic syndrome.Methods. Wistar rats were divided into two groups: control (C) and fructose (F – water with 10% of fructose). After two weeks, the F group was subdivided into four groups: F, the same as before; fructose + arginine (FA – 880 mg/kg/day of L-arginine by gavage); fructose + training (FT); and fructose + arginine + training (FTA). Treatment lasted for eight weeks.Results. The fructose administration was able to increase the collagen-induced platelet aggregation (27.4 ± 2.7%) when compared to the C group (8.0 ± 3.4%). Although the arginine supplementation (32.2 ± 6.3%) or aerobic training (23.8 ± 6.5%) did not promote any change in platelet collagen-induced hyperaggregability, the association of arginine supplementation and aerobic exercise promoted an inhibition of the platelet hyperaggregability induced by fructose administration (13.9 ± 4.4%) (P<0.05). These effects were not observed when ADP was employed as an agonist. In addition, arginine supplementation associated with aerobic exercise promoted a decrease in interleukin-6 (IL-6) and interleukin-8 (IL-8) serum levels when compared to the fructose group, demonstrating an anti-inflammatory effect.Conclusions. Our data indicate an important role of arginine supplementation associated with aerobic exercise, reducing platelet hyperaggregability and inflammatory biomarker levels in rats under high risk to develop metabolic syndrome.

22 February 2021 in International Journal of Cardiovascular Sciences
Verified
Journal Article
Closed access
PDF file
SBStephani Correia Brazão
Stephani Correia Brazão
LALis Jappour Autran
Lis Jappour Autran
RLRosane de Oliveira Lopes
Rosane de Oliveira Lopes
CSCHRISTIANNE BRETAS VIEIRA SCARAMELLO
CHRISTIANNE BRETAS VIEIRA SCARAMELLO
FBFernanda Carla Ferreira de Brito
Fernanda Carla Ferreira de Brito
NMNadia Alice Vieira Motta
Nadia Alice Vieira Motta
Chloroquine (CQ) and Hydroxychloroquine (HCQ) are antimalarial drugs, with anti-inflammatory properties that justify their use in the treatment of systemic lupus erythematosus and rheumatic diseases. A pandemic caused by the new coronavirus led the entire world’s scientific community to look for drugs already available on the market, capable of exercising beneficial actions in the fight against the disease. Preliminary studies in patients, as well as in vitro studies, suggested possible therapeutic effects associated with the use of HCQ and [...] Abstract Chloroquine (CQ) and Hydroxychloroquine (HCQ) are antimalarial drugs, with anti-inflammatory properties that justify their use in the treatment of systemic lupus erythematosus and rheumatic diseases. A pandemic caused by the new coronavirus led the entire world’s scientific community to look for drugs already available on the market, capable of exercising beneficial actions in the fight against the disease. Preliminary studies in patients, as well as in vitro studies, suggested possible therapeutic effects associated with the use of HCQ and